Free provider profile
STEPHANIE PARENT, RN
NPI 1902514375
Individual
Clinical Nurse Specialist, Psych/Mental Health
Active registration
Save to rep workspaceNPI registry Registry record
Source: CMS NPPES registry, updated continuously. This record was last updated 2023-03-19.
435 SHREWSBURY ST, WORCESTER, MA, 01604
413-537-6549
Single practice location
Enumerated 2022-11-14
- — Registration is active in NPPES.
- — Individual clinician record — reachable, but usually not the buyer.
- — Practice phone number is published.
- — Full street address on file for route planning.
- — 3 taxonomies listed — broader service mix.
- — Record last updated 3 years ago.
Medicare Part D prescribing
Source: CMS Medicare Part D Prescribers by Provider, most recent public year.
Part D claims
631
Medicare patients
41
Part D drug cost
$85,145
Brand-name share
8.4%
of this prescriber's Part D claims
| Drug | Claims | Medicare cost |
|---|---|---|
| Invega Sustenna (Paliperidone Palmitate) | 12 | $25,470 |
| Lurasidone Hcl (Lurasidone Hcl) | 21 | $3,612 |
| Venlafaxine Hcl Er (Venlafaxine Hcl) | 56 | $943 |
| Dextroamphetamine-Amphet Er (Dextroamphetamine/Amphetamine) | 42 | $808 |
| Dextroamphetamine-Amphetamine (Dextroamphetamine/Amphetamine) | 30 | $472 |
| Trazodone Hcl (Trazodone Hcl) | 33 | $382 |
| Sertraline Hcl (Sertraline Hcl) | 16 | $303 |
| Bupropion Xl (Bupropion Hcl) | 19 | $302 |
Want their full drug mix and peer benchmark? Run the free Part D prescriber lookup.
Spravato (esketamine) Medicare billing
Source: CMS Medicare Part B fee-for-service, HCPCS G2082/G2083.
202458 sessions · 12 patients · $49,567
Full Spravato label-compliance detail — sessions per patient against the FDA label, risk flags and year-over-year trend.
- Registry data comes straight from CMS NPPES, which lists registration, not activity — a listed practice may have moved or closed.
- Part D covers Medicare prescription drug enrollees only. Commercial, Medicaid and cash-pay prescribing is not included, so these figures are a floor on real volume, not the whole picture.
- CMS publishes the Part D file annually, roughly two years behind the prescribing year. Drugs with 10 or fewer claims are suppressed.